je.st
news
Home
› BellBrook Labs Launches Second Generation Transcreener EPIGEN Methyltransferase Assay To Acclerate Epigenetic Drug Discovery
BellBrook Labs Launches Second Generation Transcreener EPIGEN Methyltransferase Assay To Acclerate Epigenetic Drug Discovery
2013-08-15 06:45:51| drugdiscoveryonline News Articles
Methyltransferasesare key players in epigenetic control of gene expression and have become the targets of intensive public and private drug discovery efforts
Tags: generation
drug
discovery
labs
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|